Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials
November 05, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made an announcement yesterday that should have investors excited that the company's Phase 3 clinical trials may have...
Nuvilex Announces Cloning of Cells for Future Phase 3 Clinical Trials Initiated by Inno Biologics
November 04, 2013 09:56 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Nov 4, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases,...
Is Nuvilex Ready to Acquire Diabetes Technology and Control Cancer and Diabetes Cell Encapsulation Markets?
November 01, 2013 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Nov 1, 2013) - With October behind us, Nuvilex, Inc. (OTCQB: NVLX) investors should see a new acquisition this month. Two weeks ago Stock Market Media Group, a...
New Study Continues to Validate Nuvilex's Approach to Medical Marijuana Research
October 22, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 22, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary, Medical Marijuana Sciences, Inc., received another validation of their efforts to bring research...
Nuvilex, Inc.'s COO, Dr. Gerald Crabtree, Interviews With Stock Market Media Group
October 17, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 17, 2013) - Nuvilex Inc.'s, (OTCQB: NVLX) Chief Operating Officer, Dr. Gerald Crabtree sat down for an interview with Stock Market Media Group, a research and...
Nuvilex Featured in Recent Forbes and New York Post Articles
October 09, 2013 09:15 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Oct 9, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of...
Nuvilex, Inc.'s Marijuana Research Into Cannabidiol Could Lead to Many Successes
October 03, 2013 10:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 3, 2013) - Nuvilex, Inc. (OTCQB: NVLX) formed its subsidiary, Medical Marijuana Sciences, Inc., to study the medical applications of marijuana, and more...
Nuvilex, Inc. Enters Most Important Step of Phase III Trials Outside of Patient Enrollment
October 01, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Oct 1, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) announced that it had contracted Inno Biologics to generate cell clones that will be the basis of the company's future...
Nuvilex, Inc. Names Two Significant Partners on Its Way to Phase 3 Clinical Trials
September 19, 2013 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made another subtle but significant move this week that seems to signal the company is in "go-mode" on its future Phase III...
Nuvilex Eyes FDA Fast Track After ABRAXANE Approved for Pancreatic Cancer
September 11, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 11, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its shareholders enjoyed what could be a dress rehearsal of their own future with the Food and Drug Administration's...